Cargando…
HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
Autor principal: | Curtiss, Frederic R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437850/ https://www.ncbi.nlm.nih.gov/pubmed/18439055 http://dx.doi.org/10.18553/jmcp.2008.14.3.316 |
Ejemplares similares
-
Chasing Quality - Clinical Practice Guidelines and HEDIS Measures of Asthma and Depression Therapy Management
por: Curtiss, Frederic R.
Publicado: (2006) -
What Should Be Done About Bias and Misconduct in Clinical Trials?
por: Fairman, Kathleen A., et al.
Publicado: (2009) -
Polycystic ovary syndrome: What more can be done for patients?
por: The Lancet Regional Health – Europe
Publicado: (2022) -
Biodegradable Iron-Based Materials—What Was Done and What More Can Be Done?
por: Gąsior, Gabriela, et al.
Publicado: (2021) -
Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)